Privacy Policy

PLEASE READ THIS PRIVACY STATEMENT CAREFULLY. Privacy is very important to us. We also understand that privacy is very important to you. This Privacy Statement tells you how we protect and use information that we gather through this United Therapeutics Corporation Web site. United Therapeutics Corporation and its affiliates also operate other Web sites. This Privacy Statement does not apply to the other United Therapeutics Corporation Web sites. You should review the privacy statement posted on other United Therapeutics Corporation Web sites when you visit them. This Web site and this Privacy Statement are intended only for audiences in the U.S.

This Privacy Statement was last revised on June 19, 2009. We may change this Privacy Statement at any time and for any reason. Significant changes to the Privacy Statement are discussed below in the Section called "Changes to the Privacy Statement." We encourage you to review this Privacy Statement each time you visit the Web site.

By using this Web site, you agree to the terms of the most recent version of this Privacy Statement. Please read our Terms of Use to understand the general rules about your use of this Web site. Except as written in any other disclaimers, policies, Terms of Use, or other notices on this Web site, this Privacy Statement and the Term of Use are the complete agreement between you and United Therapeutics Corporation with respect to your use of this Web site.

INTRODUCTION
We are pleased to post this policy so that users understand how we utilize the information they provide us. For other important information concerning your use of our site, please refer to our Terms of Use. United Therapeutics Corporation respects the privacy of those who use its site. Users should understand, however, that by the very nature of the medium, their communications with us, such as postings to the site or e-mail, reveal their e-mail addresses and other potentially identifying information. The information we receive, and how we use it, depends on what you do when visiting our Web site. We collect and use your non-personal information (information that is not identifiable to you personally) differently than your personal information.

WHAT IS NON-PERSONAL INFORMATION?

Non-personal information is information we collect through this Web site that does not identify you as an individual person. It includes any of the following items:
  • the type of Web browser software you use (for example, Netscape Navigator or Internet Explorer)
  • the name of the domain from which you access the Internet (including client and server IP addresses, usernames, ports, queries, or other status-related information);
  • the Internet address of the Web site from which you linked directly to our Web site;
  • the date and time you access our Web site;
  • which pages you have visited on our Web site

WHAT DOES UNITED THERAPEUTICS CORPORATION DO WITH NON-PERSONAL INFORMATION?
Because non-personal information cannot identify you or be tied to you in any way, there are few restrictions on the ways that we can use or share non-personal information. Primarily, we will use this data to make enhancements to the Web site that are specifically tailored to improve the experience of the user community. One way that we use non-personal information is to demonstrate user trends on the Web site. Often, this is done by aggregating the data gleaned from non-personal information. This aggregated, de-identified data might be shared with outside parties who are employed to implement improvements to the site.

WHAT IS PERSONAL INFORMATION?

Personal information is information we collect through this Web site that we can use to specifically identify you, such as your:
  • name
  • telephone number
  • e-mail address
  • state of residence
  • age range
  • gender
  • name of your physician
  • whether you are a patient or caregiver
  • why you are participating in the program

In some places on this Web site you have the opportunity to send us personal information about yourself. For example, you may fill out a registration form, a survey, or an email form.

Any personal information that you enter on this Web site will not be revealed to third parties or used for any purpose outside of United Therapeutics Corporation.

HOW DOES UNITED THERAPEUTICS CORPORATION KEEP AND USE PERSONAL INFORMATION?
Please note, United Therapeutics Corporation and its agents comply with HIPAA (Health Information Portability and Accountability Act) in the collection and use of your personally identifiable health information. When you register on Adcirca.com, you are giving United Therapeutics Corporation permission to use your personal information to communicate with you. Your information will never be shared with a third party, except as outlined below.

We may keep and use personal information we collect from you through this Web site to provide you with access to this Web site. In addition, we may keep and use your personal information:

  • to send you information you requested
  • to respond to your requests
  • to develop records, including records of your personal information
  • for internal program monitoring. Never for personal reporting purposes.
  • to remove your personal identifiers (your name, e-mail address, etc). In this case, you would no longer be identified as a single unique individual. Once we have de-identified information, it is non-personal information and we may treat it like other non-personal information.
  • to enforce this Privacy Statement and other rules about your use of this Web site
  • to protect our rights or property
  • to protect someone's health, safety, or welfare
  • to comply with a law or regulation, court order or other legal process

How the Information is Used
We respect the information you submit. Your information will be used only for internal program monitoring.

We will not use, sell, or assign your e-mail address for any purpose other than to communicate with you about United Therapeutics Corporation products.

Your password will be used to keep your information secure and help us build your personalized Web page when you login.

DOES UNITED THERAPEUTICS CORPORATION EVER SHARE PERSONAL INFORMATION WITH THIRD PARTIES?
United Therapeutics Corporation will not share your personal information collected from this Web site with an unrelated third party without your permission.

In the ordinary course of business, we will share some personal information with companies that we hire to perform services or functions on our behalf. For example, we employ a company to develop and maintain this Web site. In this case, the company will have access to your personal information in the ordinary course of business. However, in this instance, and all instances in which your personal information is shared with a third party, we will not authorize them to keep, disclose, or use your information with others except for the purpose of providing the services we asked them to provide.

We will not sell, exchange, or publish your personal information, except in conjunction with a corporate sale, merger, dissolution, or acquisition.

We may be legally compelled to release your personal information in response to a court order, subpoena, search warrant, law, or regulation. We may cooperate with law enforcement authorities in investigating and prosecuting Web site visitors who violate our rules or engage in behavior which is harmful to other visitors (or illegal).

We may disclose your personal information to third parties if we feel that the disclosure is necessary to:

  • enforce this Privacy Statement and the other rules about your use of this Web site
  • protect our rights or property
  • protect someone's health, safety, or welfare
  • comply with a law or regulation, court order, or other legal process

Please note: In addition to the ways that we may keep, disclose, and use information described in this Privacy Statement, we also may keep, disclose, and use personally identifiable information that you give us through this Web site in ways that we believe are consistent with FDA and other governmental guidance, directions, regulations, and laws.

WHAT HAPPENS IF THE PRIVACY STATEMENT CHANGES?
If we decide to make a significant change to our Privacy Statement, we will post a notice on the homepage of our Web site for thirty (30) days after the change is made. United Therapeutics Corporation reserves the right to change the terms of our Privacy Statement at any time in its sole discretion. Please periodically revisit this page to stay current on any changes and to update your preferences accordingly.

WHAT ABOUT PRIVACY ON OTHER WEB SITES?
This Web site may contain links to other Web sites. Some of those Web sites may be operated by United Therapeutics Corporation, and some may be operated by third parties. We provide the links for your convenience, but we do not review, control, or monitor the activities or privacy practices of Web sites operated by others, and we do not endorse, condone, adopt, or accept liability for any statements made on Web sites to which we provide links. This Privacy Statement does not apply to any other Web site, even those owned by United Therapeutics Corporation. We are not responsible for the performance of Web sites operated by third parties or for your business dealings with them. Therefore, whenever you leave this Web site, we recommend that you review each Web site's privacy practices and make your own conclusions regarding the adequacy of these practices.

DOES UNITED THERAPEUTICS CORPORATION EVER COMMUNICATE DIRECTLY WITH VISITORS TO THIS WEB SITE? With your express permission, we may contact you periodically by e-mail, mail, or telephone to provide information regarding programs, services and content that may be of interest to you. In addition, some of the features on this Web site allow you to communicate with us using an online form. If your communication requests a response from us, we will send you a response via e-mail. The e-mail response or confirmation may include your personal information, including personal information about your health, your name, address, etc. We cannot guarantee that our e-mails to you will be secure from unauthorized interception.

ARE THERE SPECIAL RULES ABOUT CHILDREN'S PRIVACY?
We care about protecting the online privacy of children. This Web site is not intended for use by children under the age of 18. We will not intentionally collect any personal information (such as a child's name or e-mail address) from children under the age of 18. If you are a child under age 18, please do not send us any information about yourself. If you think that we have collected personal information from a child under the age of 18, please contact us. We encourage all parents and guardians to monitor their children’s use of the internet.

WHAT ABOUT WEB SITE SECURITY?
We take reasonable steps to protect your personal information from loss, misuse, and unauthorized access, disclosure, alteration, or destruction. You should keep in mind that no Internet transmission is ever 100% secure or error-free. In particular, e-mail sent to or from this site may not be secure, and you should therefore take special care in deciding what information you send to us via e-mail.

HOW TO CONTACT UNITED THERAPEUTICS CORPORATION.
If you have questions or comments about this Privacy Statement, please contact:
Alyssa Friedrich
Senior Vice President, Human Resources & Corporate Development
United Therapeutics Corporation
afriedrich@unither.com

Indication

Adcirca is a prescription medication used to treat pulmonary arterial hypertension (WHO Group 1) to improve exercise ability.

Important Safety Information for Adcirca

You should discuss all of your medical conditions and all medications with your doctor before starting Adcirca.

Do not take Adcirca if you take any medications that contain nitrates (often used for chest pain), as the combination could cause a sudden, unsafe drop in blood pressure.

Do not take Adcirca if you are allergic to tadalafil or any other ingredient in Adcirca.

If you experience chest pain after taking Adcirca, contact your doctor.

Adcirca is a type of medication called a PDE-5 inhibitor. Adcirca contains the same ingredient (tadalafil) as Cialis, which is used to treat erectile dysfunction (impotence). If you are taking Adcirca, do not take Cialis or other PDE-5 inhibitors.

PDE-5 inhibitors can cause blood vessels to widen, which may result in a decrease in blood pressure. If you have heart-disease or any problems with low blood pressure, tell your doctor before taking Adcirca, as these conditions may be affected by the action of Adcirca. If you have ever had blockage in the veins of your lungs, known as pulmonary veno-occlusive disease (PVOD), Adcirca is not recommended for you.

Do not take Adcirca if you are taking rifampin (an antibiotic for certain bacterial infections), or antifungal medications, such as ketoconazole and itraconazole. If you require treatment with both Adcirca and ritonavir (Norvir) at the same time, your dose of Adcirca will need to be adjusted. Taking Adcirca with alcohol, or blood pressure medications, such as alpha-blockers, may lower blood pressure and cause hypotension (fainting). Inform your doctor if you have kidney or liver problems before taking Adcirca.

In rare cases, men taking PDE-5 inhibitors (including tadalafil) for erectile dysfunction reported side effects such as a sudden decrease or loss of vision or hearing, or an erection lasting more than four hours. If you experience any of these side effects, seek medical attention right away.

The most common side effects of Adcirca are headache, muscle pain, getting red or hot in the face (flushing), nausea, pain in the arms, legs or back, upset stomach, stuffy or congested nose.

Click here for Full Prescribing Information and Patient Information or call 1-800-545-5979.

Close Window

Leaving Adcirca.com

You have just clicked on a link that will take you outside the Adcirca website. United Therapeutics Corporation does not monitor, does not imply any endorsement, and is not responsible for the content on outside websites.


Click "OK" to proceed to this third-party website or "CANCEL" to return to Adcirca.com.


Close WindowClose Window
Close Window

Leaving Adcirca.com and going to the United Therapeutics Corporation website

You have just clicked on a link that will take you to the United Therapeutics Corporation website (Unither.com), which has information about Adcirca, as well as other medications.


Click "OK" to proceed to the Unither.com website or "CANCEL" to return to Adcirca.com.


Close WindowClose Window
Close Window

Leaving Adcirca.com and Going to the Living PAH Website

You have just clicked on a link that will take you outside the Adcirca website to the Living PAH website.


Click "OK" to proceed to the Unither.com website or "CANCEL" to return to Adcirca.com.


Close WindowClose Window
Close Window

Thank You for Registering!

If you would like to learn more about United Therapeutics Corporation, visit www.unither.com.


Close Window

Duplicate e-mail

The database has detected that you've already registered with this e-mail address. You do not need to register for updates again. Thank you for your interest in Adcirca!


Close Window

Functional Classifications of PAH

This classification was created by the New York Heart Association (NYHA) to measure the degree of disease severity in patients with PAH. The World Health Organization (WHO) developed a similar functional class system that is also commonly used in assessing patients with PAH.


Close Window

Thank You for Sharing Your Story!

Your story will now be considered for posting on Adcirca.com. Please note that not all submitted stories will be posted. Thanks for your enthusiasm and support!


Close Window

Electronic Reprint System
Mobile™ ePrint

Hello,

Welcome to the electronic reprint system. Your Mobile™ ePrint is ready for download.

We recommend that you “Save” the file to your desktop for portability.

*** IMPORTANT NOTICE ***
This Mobile™ ePrint is ONLY supported on the PC platform. Mac users please click here for support.

To save your ePrint – Please follow these steps:

Step 1. To download the file, click on the Download File link provided below.

Step 2. To save the file to your desktop, click the “Save” button.

Step 3. Locate the file on your desktop and double click to open.

Download File - LWW_161918_CP.exe


How do I launch my Mobile™ ePrint for the first time?

Simply click on the “Download File” link that is embedded in this email. You will be prompted to either “Run” or “Save” the ePrint file. We recommend you save the ePrint file to a location on your computer where you can locate and activate it at a later time. To open the saved ePrint file simply double-click on the file icon you saved to your computer. You must be connected to the Internet the first time you open your ePrint. This one-time Internet connection allows your ePrint to validate itself.

Click here for more information.

Please email us at requestinfo@tsp.sheridan.com for any ePrint support questions.

Thank you for your order!